Vasomune Therapeutics is Biotechnology in Canada that focus on drug candidate business. Founded in 2012. They cover business area such as developer, biotechnology platform, target disease, vascular dysfunction, destabilization, barrier defense, injury, doctor, patient, illness.
2012
( 14 years old in 2026 )
Drug Candidate
-
180 John Street
Suite 305
Toronto, Ontario M5T 1X5
Canada
Private
developerbiotechnology platformtarget diseasevascular dysfunctiondestabilizationbarrier defenseinjurydoctorpatientillness
* We use standard office opening hours in near Vasomune Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vasomune Therapeutics is Biotechnology business from Canada that founded in 2012 (14 years old in 2026), Vasomune Therapeutics business is focusing on Drug Candidate.
Vasomune Therapeutics headquarter office and corporate office address is located in 180 John Street Suite 305 Toronto, Ontario M5T 1X5 Canada.
Vasomune Therapeutics was founded in Canada.
In 2026, Vasomune Therapeutics is currently focus on drug candidate sector.
Above is snippet of Google Trends for "drug candidate" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vasomune Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
